Oral mucosal lipids are antibacterial against Porphyromonas gingivalis, induce ultrastructural damage, and alter bacterial lipid and protein compositions.
about
The silencing of cathepsin K used in gene therapy for periodontal disease reveals the role of cathepsin K in chronic infection and inflammation.Phylogenetic and functional gene structure shifts of the oral microbiomes in periodontitis patients.Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking.In vivo microstructural analysis of enamel in permanent and deciduous teeth.Targeting Atp6v1c1 Prevents Inflammation and Bone Erosion Caused by Periodontitis and Reveals Its Critical Function in OsteoimmunologyAntibacterial effects of Lactobacillus and bacteriocin PLNC8 αβ on the periodontal pathogen Porphyromonas gingivalis.Deficiency of cathepsin K prevents inflammation and bone erosion in rheumatoid arthritis and periodontitis and reveals its shared osteoimmune role.Protein Analysis of Sapienic Acid-Treated Porphyromonas gingivalis Suggests Differential Regulation of Multiple Metabolic PathwaysAntimicrobial Activity of Chemokine CXCL10 for Dermal and Oral Microorganisms.Promise of Combining Antifungal Agents in Denture Adhesives to Fight Candida Species Infections.Assessment of epithelial innate antimicrobial factors in sinus tissue from patients with and without chronic rhinosinusitis.Phytosphingosine Prevents the Formation of Young Salivary Biofilms in vitro.d-Alanine metabolism is essential for growth and biofilm formation of Streptococcus mutans.Differential cytotoxicity of long-chain bases for human oral gingival epithelial keratinocytes, oral fibroblasts, and dendritic cells.Arachidonic acid and other unsaturated fatty acids and some of their metabolites function as endogenous antimicrobial molecules: A review
P2860
Q33828436-59049E6A-CA1D-473A-8DBB-CAF85AA239F7Q34071990-3BCBC076-B070-4B46-98C8-B5A3F9ACC339Q34373100-5CF683AF-EB12-4EC8-BC7A-73D702903E84Q35287328-B14C0182-71F2-40E9-B3FE-F8D46058478EQ35746167-47B0AC0F-EE2A-43ED-AF0D-CFF2BABE9021Q36107381-7185921F-08F5-4BCE-8DAB-0FD4E864FA2AQ36216635-3351D610-A6A4-489F-AD23-89E8EE093662Q36390595-2E9CC132-49BE-4CF3-A82C-DC12F0CAB703Q39314294-4F97E418-A2E5-4BFC-941B-B77E42A21F33Q40442488-F19E2738-35AC-4C9F-950D-D6F48B9F9E5EQ41874032-E985FA4D-CFF7-471C-B14D-B7EC243BDE2CQ49894689-EE787D36-0B0D-4865-9DF9-D854F9D08E1EQ53297472-10B24DD7-C8D8-4F3E-9A6B-C65A0E5B6BF8Q53495226-8E78F138-19F2-49A0-AC7A-9D955933979BQ56975689-4A25E715-92B0-4AA5-95EC-7DC13DB4D85C
P2860
Oral mucosal lipids are antibacterial against Porphyromonas gingivalis, induce ultrastructural damage, and alter bacterial lipid and protein compositions.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Oral mucosal lipids are antiba ...... ipid and protein compositions.
@en
Oral mucosal lipids are antiba ...... ipid and protein compositions.
@nl
type
label
Oral mucosal lipids are antiba ...... ipid and protein compositions.
@en
Oral mucosal lipids are antiba ...... ipid and protein compositions.
@nl
prefLabel
Oral mucosal lipids are antiba ...... ipid and protein compositions.
@en
Oral mucosal lipids are antiba ...... ipid and protein compositions.
@nl
P2093
P2860
P356
P1476
Oral mucosal lipids are antiba ...... ipid and protein compositions.
@en
P2093
Carol L Fischer
David R Drake
Deborah V Dawson
Derek R Blanchette
Katherine S Walters
Kim A Brogden
Philip W Wertz
P2860
P2888
P304
P356
10.1038/IJOS.2013.28
P577
2013-07-19T00:00:00Z
P5875
P6179
1031376904